
LIC MF Healthcare Fund Direct Growth
LIC MF Healthcare Fund Direct Growth
as on 06 Nov 2026
LIC MF Healthcare Fund Direct Growth is a Equity mutual fund scheme launched on 28 Feb 2019. The current NAV stands at ₹37.4275 as of 06 Nov 2026. From the funds total AUM, its top holdings include Sun Pharmaceutical at 10.61%, Divis Laboratories at 7.56%, Treps at 7.29%, Apollo Hospitals at 6.63%, Torrent Pharmaceuticals at 6.51%
Scheme Overview
- Inception Date : 28 Feb 2019
- AUM : ₹99.36 Cr
- 5Y Returns (CAGR) : 13.72%
- Expense Ratio : 1.37%
- Min. SIP : ₹200
- Min. Lumpsum : ₹5,000
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
5Y
₹ 32.73 L
3.50%
₹ 36.98 L
8.00%
₹ 43.26 L
13.72%
Total Investment
₹ 30,00,000
Returns
₹ 13,26,058 (13.72%)
Maturity Value
₹ 43,26,058
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 99.36 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹99.36 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 85.32% | ||
| Basic Materials | 7.60% | ||
| Other | 7.08% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() S Sun Pharmaceutical | 10.61% | |
![]() D Divis Laboratories | 7.56% | |
![]() T Treps | 7.29% | |
![]() A Apollo Hospitals | 6.63% | |
![]() T Torrent Pharmaceuticals | 6.51% | |
![]() N Neuland Laboratories | 5.49% | |
![]() N Navin Fluorine International | 5.38% | |
![]() A Aurobindo Pharma | 4.98% | |
![]() F Fortis Healthcare | 4.49% | |
![]() G Gland Pharma | 3.55% | |
![]() Z Zydus Life Science | 3.15% | |
![]() O Onesource Specialty Pharma | 3.08% | |
![]() A Aster DM Healthcare | 3.07% | |
![]() G Glenmark Pharmaceuticals | 3.07% | |
![]() B Biocon | 3.06% | |
![]() G Global Health | 2.97% | |
![]() M Metropolis Healthcare | 2.95% | |
![]() A Artemis Medicare Services | 2.87% | |
![]() I IPCA Laboratories | 2.85% | |
![]() M Mankind Pharma | 2.29% | |
![]() A Acutaas Chemicals | 2.22% | |
![]() A Anthem Biosciences | 2.16% | |
![]() D Dr. Agarwal's Health Care | 2.15% | |
![]() M Max Healthcare Institute | 1.82% | |
![]() N Net Receivables / (Payables) | 0.21% | |
![]() A Alkem Laboratories | 0.00% | |
![]() V Vinati Organics | 0.00% | |
![]() C Concord Biotech | 0.00% | |
![]() A Abbott | 0.00% | |
![]() P Piramal Pharma | 0.00% | |
![]() C Cipla | 0.00% |
Fund Comparison
Fund Details
52W High NAV
₹ 38.4712
Min. SIP Amount
₹ 200.00
Min. Lumpsum Amount
₹ 5,000.00
AUM (in Cr.)
₹ 99.36
Expense Ratio
1.37%
Lock-in Period
No Lock in Period
52W Low NAV
₹ 29.6241
Inception Date
28 Feb 2019
Fund Age
7 Yrs
Benchmark
BSE Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Sudhanshu Asthana | post graduate in Economics and has diploma in Investment Management |
| Dhaval Sangoi | CFA BMS, Narsee Monjee College of Commerce and Economics, Mumbai |
Fund Objective
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
LIC Mutual Fund
No. of Schemes
33
Total AUM
₹ 40,766.64 Cr
Contact Details
4th Floor, Industrial InsuranceBuilding, Opp.Churchgate StatiMumbai 400 020.
Contact Details
4th Floor, Industrial InsuranceBuilding, Opp.Churchgate StatiMumbai 400 020.
FAQs
When was LIC MF Healthcare Fund launched?
What is the current NAV of LIC MF Healthcare Fund?
What is the AUM of LIC MF Healthcare Fund?
What is the rate of return of LIC MF Healthcare Fund?
- In the past 1Y: 14.31%
- In the past 3Y: 22.20%
- In the past 5Y: 13.72%
What is the expense ratio of LIC MF Healthcare Fund?
What is exit load of LIC MF Healthcare Fund?
What is the portfolio of LIC MF Healthcare Fund?
- Sun Pharmaceutical: 10.61%
- Divis Laboratories: 7.56%
- Apollo Hospitals: 6.63%
- Torrent Pharmaceuticals: 6.51%
- Neuland Laboratories: 5.49%
Top 3 sectoral holdings include:
- Healthcare: 85.32%
- Basic Materials: 7.60%
- Others: 7.50%
How risky is investing in LIC MF Healthcare Fund?
Who is the fund manager LIC MF Healthcare Fund?
What is the minimum investment required in LIC MF Healthcare Fund?
How to invest in LIC MF Healthcare Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App
































